search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Flushing a Venous Access Port every 6 weeks; does it help to prevent thrombotic complications?


- candidate number22993
- NTR NumberNTR5554
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR21-okt-2015
- Secondary IDs201514802 201514802-1
- Public TitleFlushing a Venous Access Port every 6 weeks; does it help to prevent thrombotic complications?
- Scientific TitleRelation of thrombotic complications in children with cancer with frequency of prophylactically flushing the Venous Access Port; every 6 weeks versus never. A retrospective observational study.
- ACRONYM
- hypothesisIt is safe, in terms of rate of thrombotic complications, to refrain from prophylactically flushing the Venous Access Port (VAP) in children with cancer (compared to flushing it every six weeks) when not in use.
- Healt Condition(s) or Problem(s) studiedPediatric cancer
- Inclusion criteria- Age <18 years
- Cancer diagnosis between 01-01-2005 and 01-07-2015
- Implanted VAP despite (temporarily) discontinued intravenous treatment
- Data available on VAP implementation/replacement/removal (operative reports)
- Exclusion criteriaPatients in whom there was no consecutive period of ≥12 weeks when the VAP was not in use
- mec approval receivedno
- multicenter trialyes
- randomisedno
- groupParallel
- Type2 or more arms, non-randomized
- Studytypeobservational
- planned startdate 1-dec-2015
- planned closingdate1-apr-2016
- Target number of participants100
- InterventionsWhen VAP is not in use; flushing it every 6 weeks vs flushing it never.
- Primary outcomeThrombotic complications, defined as occlusion of the catheter, which requires VAP removal.
- Secondary outcomeTime between last VAP flushing and complication.
- Timepointsn/a
- Trial web site
- status[default]
- CONTACT FOR PUBLIC QUERIES Erik Loeffen
- CONTACT for SCIENTIFIC QUERIES Erik Loeffen
- Sponsor/Initiator University Medical Center Groningen (UMCG)
- Funding
(Source(s) of Monetary or Material Support)
None
- Publications
- Brief summaryIn this trial we will retrospectively assess if there is a difference in thrombotic complications regarding frequency of flushing the VAP (every 6 weeks versus never) when not in use, in children with cancer.
- Main changes (audit trail)
- RECORD21-okt-2015 - 4-feb-2016


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl